BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29658093)

  • 21. Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.
    White NM; Masui O; Desouza LV; Krakovska O; Metias S; Romaschin AD; Honey RJ; Stewart R; Pace K; Lee J; Jewett MA; Bjarnason GA; Siu KW; Yousef GM
    Oncotarget; 2014 Jan; 5(2):506-18. PubMed ID: 24504108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis.
    Ganti S; Taylor SL; Abu Aboud O; Yang J; Evans C; Osier MV; Alexander DC; Kim K; Weiss RH
    Cancer Res; 2012 Jul; 72(14):3471-9. PubMed ID: 22628425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Prognostic Biomarkers in the Urinary Peptidome of the Small Renal Mass.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Am J Pathol; 2019 Dec; 189(12):2366-2376. PubMed ID: 31761032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour necrosis factor receptor-associated factor-1 (TRAF-1) expression is increased in renal cell carcinoma patient serum but decreased in cancer tissue compared with normal: potential biomarker significance.
    Rajandram R; Yap NY; Pailoor J; Razack AH; Ng KL; Ong TA; Morais C; Gobe GC
    Pathology; 2014 Oct; 46(6):518-22. PubMed ID: 25158810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ARCHITECT® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results).
    Ben Khadhra H; Rose-Robert F; Herpe YE; Sevestre H; Choukroun G; Catherine L; Amant C; Saint F
    Int Urol Nephrol; 2021 Jan; 53(1):59-67. PubMed ID: 32783115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles.
    Grützmann K; Salomo K; Krüger A; Lohse-Fischer A; Erdmann K; Seifert M; Baretton G; Aust D; William D; Schröck E; Thomas C; Füssel S
    Biol Direct; 2024 May; 19(1):38. PubMed ID: 38741178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive model for recurrence of renal cell carcinoma by comparing pre- and postoperative urinary metabolite concentrations.
    Morozumi K; Kawasaki Y; Maekawa M; Takasaki S; Sato T; Shimada S; Kawamorita N; Yamashita S; Mitsuzuka K; Mano N; Ito A
    Cancer Sci; 2022 Jan; 113(1):182-194. PubMed ID: 34710258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J; Liu P; Tian M; Li Y; Chen W; Li X
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).
    Alves G; Pereira DA; Sandim V; Ornellas AA; Escher N; Melle C; von Eggeling F
    Int Braz J Urol; 2013; 39(2):228-39. PubMed ID: 23683669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine metabolomic analysis in clear cell and papillary renal cell carcinoma: A pilot study.
    Oto J; Fernández-Pardo Á; Roca M; Plana E; Solmoirago MJ; Sánchez-González JV; Vera-Donoso CD; Martínez-Sarmiento M; España F; Navarro S; Medina P
    J Proteomics; 2020 Apr; 218():103723. PubMed ID: 32126320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging role of secreted miR-210-3p as potential biomarker for clear cell Renal Cell Carcinoma metastasis.
    Petrozza V; Costantini M; Tito C; Giammusso LM; Sorrentino V; Cacciotti J; Porta N; Iaiza A; Pastore AL; Di Carlo A; Simone G; Carbone A; Gallucci M; Fazi F
    Cancer Biomark; 2020; 27(2):181-188. PubMed ID: 31771042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative proteomics in resected renal cancer tissue for biomarker discovery and profiling.
    Atrih A; Mudaliar MA; Zakikhani P; Lamont DJ; Huang JT; Bray SE; Barton G; Fleming S; Nabi G
    Br J Cancer; 2014 Mar; 110(6):1622-33. PubMed ID: 24548857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood- and Urine-Based Liquid Biopsy for Early-Stage Cancer Investigation: Taken Clear Renal Cell Carcinoma as a Model.
    Liu X; Zhang M; Shao C; Sun H; Zhang B; Guo Z; Sun J; Qi F; Zhang Y; Niu H; Sun W
    Mol Cell Proteomics; 2023 Aug; 22(8):100603. PubMed ID: 37348606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary exosome miR-30c-5p as a biomarker of clear cell renal cell carcinoma that inhibits progression by targeting HSPA5.
    Song S; Long M; Yu G; Cheng Y; Yang Q; Liu J; Wang Y; Sheng J; Wang L; Wang Z; Xu B
    J Cell Mol Med; 2019 Oct; 23(10):6755-6765. PubMed ID: 31342628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern.
    Wu DL; Zhang WH; Wang WJ; Jing SB; Xu YM
    Technol Cancer Res Treat; 2008 Jun; 7(3):155-60. PubMed ID: 18473487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics in renal cell carcinoma: From biomarker identification to pathomechanism insights.
    Chen YY; Hu HH; Wang YN; Liu JR; Liu HJ; Liu JL; Zhao YY
    Arch Biochem Biophys; 2020 Nov; 695():108623. PubMed ID: 33039388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic urinary miRNAs for the assessment of small renal masses.
    Di Meo A; Brown MD; Finelli A; Jewett MAS; Diamandis EP; Yousef GM
    Clin Biochem; 2020 Jan; 75():15-22. PubMed ID: 31672647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney.
    Yokomizo A; Takakura M; Kanai Y; Sakuma T; Matsubara J; Honda K; Naito S; Yamada T; Ono M
    Cancer Biomark; 2011-2012; 10(3-4):175-83. PubMed ID: 22674303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.